You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

ACHROMYCIN V Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Achromycin V, and when can generic versions of Achromycin V launch?

Achromycin V is a drug marketed by Avet and Lederle and is included in two NDAs.

The generic ingredient in ACHROMYCIN V is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Achromycin V

A generic version of ACHROMYCIN V was approved as tetracycline hydrochloride by WATSON LABS on December 31st, 1969.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ACHROMYCIN V?
  • What are the global sales for ACHROMYCIN V?
  • What is Average Wholesale Price for ACHROMYCIN V?
Summary for ACHROMYCIN V
Drug patent expirations by year for ACHROMYCIN V
Pharmacology for ACHROMYCIN V

US Patents and Regulatory Information for ACHROMYCIN V

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avet ACHROMYCIN V tetracycline hydrochloride CAPSULE;ORAL 050278-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Avet ACHROMYCIN V tetracycline hydrochloride CAPSULE;ORAL 050278-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lederle ACHROMYCIN V tetracycline hydrochloride SUSPENSION;ORAL 050263-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.